CAAS Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-320,426	Closed	-$2.54M	–	602
2022 Q2	$2.54M	Buy	+320,426	New	+$2.54M	0.13%	64